NR 585NP Week 5 Home BP Monitoring Appraisal Example

Course	NR 585NP Research Methods and Evidence-Based Practice for Advanced Nursing Practice
Week	5
Paper type	Evidence appraisal and synthesis
Length	About 1,450 words, 6 pages
Format	APA 7 student paper
School	Chamberlain University
Program	MSN, nurse practitioner core
Updated	October 2026

Free sample paper for NR 585NP Week 5

Self-Measured Blood Pressure Monitoring With Clinical Support for Uncontrolled Hypertension in Adult Primary Care: An Appraisal and Synthesis of the Evidence

Student Name

Chamberlain University College of Nursing

NR 585NP: Research Methods and Evidence-Based Practice for Advanced Nursing Practice

Week 5 Assignment

Professor Name

August 11, 2026

What this page is doingThe title names the population, the intervention and the genre, and the phrase with clinical support tells a reader where the paper lands before the first paragraph. An appraisal titled only self-monitoring and hypertension would promise a summary of a subject; this one promises a verdict on a specific comparison. The block keeps APA 7 student order and adds the week line the classroom template usually carries, which costs nothing and prevents a submission from being filed against the wrong week.

Practice Question and Search Strategy

Cedar Family Practice is a composite two site primary care group with an adult panel of 3,050 patients, 742 of whom carry a diagnosis of hypertension. A registry pull covering the most recent 12 months shows 268 of those 742 patients, or 36.1 percent, with readings at or above 130/80 mm Hg at two consecutive office visits, which is the practice definition of uncontrolled. The same pull shows a median of 2.1 office visits per patient per year in this group and no structured record of any reading taken between visits. Clinicians are therefore titrating medication on two or three office readings a year, a sampling problem that no amount of prescribing skill corrects.

The question in PICOT form is this: in adults with diagnosed hypertension whose office readings remain at or above 130/80 mm Hg (P), does self-measured blood pressure monitoring paired with structured clinical support (I), compared with office measurement and routine follow up alone (C), lower mean systolic blood pressure and raise the proportion of the group at goal (O) within 6 months (T)? The comparison clause carries more weight than it appears to, because much of the published work compares monitoring plus support against monitoring alone rather than against usual care, and the two comparisons answer different questions.

Three databases were searched: PubMed, CINAHL Complete and the Cochrane Library. Terms combined self-measured blood pressure, home blood pressure monitoring, self-monitoring, hypertension and primary care using the operators AND and OR, limited to English language, adult populations and publication from 2010 forward. The search returned 641 records, 388 from PubMed, 214 from CINAHL and 39 from the Cochrane Library. Removing 92 duplicates left 549 records screened by title and abstract, of which 508 were excluded; 41 full text reports were reviewed and 35 were excluded, most often for the wrong comparison group (14), no reported blood pressure outcome (9) or a setting outside primary care (8). Six sources were retained: two systematic reviews with meta-analysis, three randomized trials and one clinical practice guideline. Counts are reported in the flow format of the PRISMA 2020 statement so that another reader could repeat the search and arrive at the same set (Page et al., 2021).

What this page is doingTwo moves earn credit here. The registry numbers make the question local rather than abstract, so the paper is appraising evidence for a decision that exists. The search paragraph then reports databases, terms, limits, yields and reasons for exclusion, which is what separates a search from a claim of having searched. Naming the comparison clause in the PICOT sentence is the quiet expert move, since a reader who misses it will misread every effect size that follows.

Appraisal: Ranking the Strength of the Retained Evidence

Each retained source was placed in the seven level hierarchy used throughout the course, in which Level I is a systematic review or meta-analysis of randomized trials and Level VII is the opinion of authorities (Melnyk & Fineout-Overholt, 2023). Both syntheses sit at Level I. Glynn et al. (2010) pooled more than 70 randomized trials of strategies for improving blood pressure control and reported that self-monitoring on its own produced only a modest net reduction, while the larger and steadier effects came from an organized system of regular review paired with a stepped medication protocol, including nurse led and pharmacist led care wherever a titration algorithm was already in place.

The second Level I source is the comparative effectiveness review published by the Agency for Healthcare Research and Quality (2012), which compared self-measured monitoring against usual care and against monitoring with additional support. It reported systolic differences favoring self-monitoring in the range of roughly 2 to 4 mm Hg at 6 months against usual care, with larger and better sustained differences wherever monitoring was paired with counseling, education, or medication titration by a clinician or pharmacist. Risk of bias across the pooled trials was mixed, since blinding of participants is impossible in this design and several trials reported incomplete outcome data at their longest follow up.

The three randomized trials retained at full text are Level II evidence, and because both reviews already pool them, they are counted once here and reported inside the review evidence rather than as separate entries, which keeps the same participants from being weighed twice. As a group they carry the strengths and the weaknesses of the design. Randomization and concealed allocation protect the comparison, and blood pressure is a device measured outcome rather than a self-reported one. Against that, no trial could blind participants to whether they were measuring at home, follow up ran 6 to 12 months rather than years, and the support arms differed enough that the pooled effect describes a family of interventions rather than one protocol.

The clinical practice guideline is not a level in this hierarchy. It is a recommendation built on one, so it is appraised for the strength of the evidence behind each statement rather than for a design of its own. The 2017 guideline for adults recommends out of office measurement both to confirm a diagnosis of hypertension and to support titration, and it sets a treated goal below 130/80 mm Hg for most adults (Whelton et al., 2018). Rated as a body, the evidence is moderate: the direction of effect is consistent across Level I and Level II sources, the magnitude is small and depends on the support attached to monitoring, and certainty is held down by unblinded designs and short follow up.

What this page is doingThe appraisal ranks rather than lists. Each source gets a level, a reason for that level, and a named weakness, and the guideline is deliberately refused a level because a recommendation is not a design. The refusal to count trials twice once they are pooled inside a review is the kind of detail graders read as command of method. The section then closes by rating the whole body, not just the parts, which is the step most papers at this level skip.

Synthesis of the Body of Evidence

The synthesis reads in one line: monitoring changes little on its own, and the clinical support attached to it carries the effect. Every retained source points the same way on that point, which is why the finding survives the moderate certainty rating. What the sources disagree about is the size of the benefit and the form the support should take, and that disagreement is the reason a practice cannot simply hand out devices and expect the registry to move. The intervention worth adopting is a measurement series plus a scheduled clinical response, and the second half is the half that is usually dropped.

That reading fits this practice unusually well, because Cedar Family Practice already holds the harder half. A nurse care coordinator and a standing prescribing protocol for hypertension are in place and underused, so the evidence argues for changing the pathway rather than the formulary. Two things the evidence does not settle should be stated with equal clarity. It does not establish how long any gain persists beyond a year, and it does not identify which patients benefit most, since the pooled trials were not powered for subgroups by age, race or baseline severity.

What this page is doingA synthesis is not a summary, and this section proves the difference by stating the finding in one sentence and then saying what the sources disagree about. Naming the two questions the evidence does not settle protects the writer twice: it shows the reading was careful, and it stops the recommendation that follows from overreaching. Fitting the finding to a resource the practice already owns is also what makes the later change plausible rather than aspirational.

The Practice Change and How It Would Be Measured

Concretely, each of the 268 uncontrolled patients would be issued or verified on a validated upper arm device with a correctly sized cuff, then asked to record duplicate morning and evening readings for 7 consecutive days, discarding day one and averaging the remainder, which is the measurement form described in the Million Hearts (2014) clinician tool. The averaged series would be entered in the record and reviewed by the nurse care coordinator at week 2 and week 6, with titration under the standing protocol and a clinician visit at week 12. No telemonitoring hardware would be purchased, because the evidence for transmitted readings above a recorded series with support was not consistent enough to carry that spend.

Three measures would be tracked against a fixed denominator of those 268 patients: the proportion with a complete 7 day series documented within 90 days of enrollment, mean change in systolic blood pressure at 6 months, and the proportion at or below 130/80 mm Hg at 6 months. Baseline for the second and third measures is the registry pull described earlier, so the comparison is against the same patients rather than against a different year's panel. A process measure without an outcome measure would let the practice congratulate itself for collecting readings nobody acted on, and an outcome measure without a process measure would leave a null result impossible to interpret.

Three limits belong on the record before the change is proposed. Device cost falls on the patient under most plans, and the group serves a share of uninsured adults for whom a validated monitor is a real expense, so the change is equitable only if a loaner supply is part of it. Arm circumference above the range of a standard cuff is common enough that sizing has to be checked rather than assumed, since an undersized cuff overstates pressure and would manufacture a treatment decision. Finally, the retained evidence follows patients for 6 to 12 months, so no claim about control sustained past a year can be made from it, and the practice should say so when it reports results.

What this page is doingThis is the part rubrics ask for and papers usually leave vague. The change is specific enough to be carried out by someone else, the measure set has a fixed denominator of 268 so a percentage means something, and the pairing of process with outcome is defended rather than assumed. Ending on cost, cuff size and duration keeps the recommendation inside the evidence, which is where a reader checks whether the appraisal changed the writer's mind or only decorated it.

References

Agency for Healthcare Research and Quality. (2012). Self-measured blood pressure monitoring: Comparative effectiveness (Comparative Effectiveness Review No. 45; AHRQ Publication No. 12-EHC002-EF). U.S. Department of Health and Human Services. https://effectivehealthcare.ahrq.gov/products/self-measured-blood-pressure/research

Glynn, L. G., Murphy, A. W., Smith, S. M., Schroeder, K., & Fahey, T. (2010). Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews, 2010(3), Article CD005182. Cochrane Library. https://www.cochranelibrary.com

Melnyk, B. M., & Fineout-Overholt, E. (2023). Evidence-based practice in nursing and healthcare: A guide to best practice (5th ed.). Wolters Kluwer.

Million Hearts. (2014). Self-measured blood pressure monitoring: Action steps for clinicians. Centers for Disease Control and Prevention. https://millionhearts.hhs.gov/tools-protocols/tools/smbp.html

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hrobjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., ... Wright, J. T., Jr. (2018). 2017 guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13-e115. https://doi.org/10.1161/HYP.0000000000000065

NR 585NP Week 5 instructions, in plain terms

Many sections use the fifth week of this course for an appraisal or synthesis of the evidence behind one clinical question. Chamberlain does not publish weekly deliverable names here, so the instructions and rubric in your classroom set the required sections. Write the question in PICOT form and pay close attention to the comparison clause. Report the search with databases, terms, limits, yields, duplicates, exclusions with reasons and the final count, in prose or in a diagram as your rubric allows. Give each source a level tied to its design, then rate the whole body for consistency, size of effect and certainty. End with a specific change and the measures that would show whether it worked.

How the NR 585NP Week 5 example is put together

The question section uses a registry pull to show 36.1 percent of hypertensive adults uncontrolled and no record of readings between visits. The search moves from 641 records through 92 duplicates and 508 title exclusions to 41 full texts, with exclusions sorted by reason. Glynn and colleagues (2010) and the AHRQ review (2012) sit at Level I, three trials are counted inside them, and the 2017 guideline is appraised for its evidence rather than given a level. The synthesis fits the finding to a nurse care coordinator and protocol the practice already has. The change uses a 7 day duplicate reading series from Million Hearts, coordinator review at weeks 2 and 6, and three measures.

NR 585NP Week 5 rubric: what full points look like

Appraisal and synthesis rubrics in nurse practitioner research courses typically award points for the clinical question, the search strategy, the appraisal of individual sources, the synthesis of the body of evidence, the practice recommendation and APA. Appraisal and synthesis usually account for the largest share. This paper earns them by leveling each source with a stated reason, refusing to count pooled trials twice, and rating the body as moderate with the reasons that hold certainty down. The search row is met because every count is reported. The recommendation scores for a fixed denominator of 268, paired process and outcome measures, and stated limits. Six references support the APA row.

NR 585NP Week 5 help: mistakes that cost points

Papers lose ground when they summarize each study in turn and never rate the evidence as a whole. Another frequent problem is a comparison clause that does not match what the studies compared, which makes every effect size misleading. Students also count the same trial twice, inside a review and on its own, or assign a level to a guideline. A search reported without yields and reasons for exclusion cannot be repeated. Recommendations that buy technology the evidence does not support, or that ignore cost and cuff size, overreach. If your clinical question differs, send it with your sources, and an NR 585NP appraisal can be written to that evidence.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Chamberlain University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More NR 585NP papers and MSN samples

NR 585NP Week 5 questions, answered

What does NR 585NP Week 5 usually ask for?

Chamberlain does not publish week by week deliverable names for this course, so read the week's instructions first. In many sections a midterm week in a research and evidence-based practice course asks you to appraise or synthesize evidence behind one clinical question, often with a search strategy attached. The rubric in your classroom sets the required sections; an example like this one shows the shape they usually take.

How do I rank the strength of evidence in this kind of paper?

Rank twice. Give each source a level from the hierarchy your course uses, with a reason tied to design rather than to how convincing you found it. Then rate the body as a whole for consistency of direction, magnitude of effect and certainty, naming what holds the certainty down. A paper that levels the parts but never rates the whole stops one step short.

Do I need a PRISMA diagram, a table, or can the search go in the prose?

Follow the rubric in your classroom, since some sections require a table or a diagram and some do not. When prose is allowed, report the same elements a diagram would: databases, search terms, limits, records returned, duplicates removed, records screened, full text reviewed, exclusions with reasons, and the final retained count. The example above carries all of that in one paragraph.

Where can I find a free NR 585NP Week 5 sample paper?

The complete self-measured blood pressure appraisal is printed on this page, question and search through six references, with a teaching note for each sheet.

What does the NR 585NP Week 5 example find carries the effect of home monitoring?

The structured clinical support paired with it, such as scheduled review and medication titration, rather than the device alone; monitoring by itself produced only modest reductions.